Cubist Systematic Strategies’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.66M | Sell |
|
|||||
|
2025
Q1 | $4.9M | Buy |
|
|||||
|
2024
Q4 | $5.05M | Buy |
|
|||||
|
2024
Q3 | $417K | Sell |
|
|||||
|
2024
Q2 | $2.13M | Buy |
|
|||||
|
2024
Q1 | $1.37M | Sell |
|
|||||
|
2023
Q4 | $1.2M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $2.59M | Buy |
|
|||||
|
2022
Q4 | $287K | Sell |
|
|||||
|
2022
Q3 | $1.04M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $571K | Sell |
|
|||||
|
2021
Q4 | $2.2M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $237K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $1.19M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $1.48M | Buy |
|
|||||
|
2020
Q1 | $490K | Buy |
|
|||||
|
2019
Q4 | $604K | Buy |
|
|||||
|
2019
Q3 | $332K | Sell |
|
|||||
|
2019
Q2 | $1.15M | Buy |
|
|||||
|
2019
Q1 | $1.01M | Buy |
|
|||||
|
2018
Q4 | $625K | Buy |
|
|||||
|
2018
Q3 | $484K | Buy |
|
|||||
|
2018
Q2 | $203K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $293K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $72K | Sell |
|
|||||
|
2016
Q3 | $393K | Buy |
|
|||||
|
2016
Q2 | $254K | Buy |
|
|||||
|
2016
Q1 | $148K | Sell |
|
|||||
|
2015
Q4 | $185K | Sell |
|
|||||
|
2015
Q3 | $405K | Sell |
|
|||||
|
2015
Q2 | $687K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $135K | Sell |
|
|||||
|
2014
Q3 | $199K | Buy |
|